Daglig behandling med 2, 5 mg Bonviva resulterede i en tiltagende øgning af BMD både vertebralt og non- vertebralt.
Daily treatment with 2.5 mg resulted in progressive increases in BMD at vertebral and nonvertebral sites of the skeleton.